Global Active Pharmaceutical Ingredient Industry 2016 Deep Market Research Report

Table of Contents
1 Industry Overview of Active Pharmaceutical Ingredient 1
1.1 Definition and Specifications of Active Pharmaceutical Ingredient 1
1.1.1 Definition of Active Pharmaceutical Ingredient 1
1.1.2 Authority Agency Definition of Active Pharmaceutical Ingredient 1
1.2 Classification of Active Pharmaceutical Ingredient 2
1.2.1 Synthetic API 4
1.2.2 Biotech API 5
1.2.3 Other 6
1.3 Applications of Active Pharmaceutical Ingredient 6
1.4 Industry Chain Structure of Active Pharmaceutical Ingredient 8
1.5 Industry Overview and Major Regions Status of Active Pharmaceutical Ingredient 9
1.5.1 Global Major Regions Status of Active Pharmaceutical Ingredient 9
1.5.2 Industry Overview of Active Pharmaceutical Ingredient 10
1.6 Industry Policy Analysis of Active Pharmaceutical Ingredient 11
1.6.1 United States Policy Analysis 12
1.6.2 Europe Policy Analysis 14
1.7 Industry News Analysis of Active Pharmaceutical Ingredient 15
2 Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient 17
2.1 Raw Material Suppliers and Price Analysis of Active Pharmaceutical Ingredient 17
2.1.1 M-Cresol 18
2.1.2 Corn Starch 18
2.2 Equipment Suppliers and Price Analysis of Active Pharmaceutical Ingredient 22
2.3 Labor Cost Analysis of Active Pharmaceutical Ingredient 22
2.4 Other Costs Analysis of Active Pharmaceutical Ingredient 25
2.5 Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient 28
2.6 Manufacturing Process Analysis of Active Pharmaceutical Ingredient 29
3 Technical Data and Manufacturing Plants Analysis of Active Pharmaceutical Ingredient 30
3.1 Capacity and Commercial Production Date of Global Active Pharmaceutical Ingredient Major Manufacturers in 2015 30
3.2 Manufacturing Plants Distribution of Global Active Pharmaceutical Ingredient Major Manufacturers in 2015 31
3.3 R&D Status of Global Active Pharmaceutical Ingredient Major Manufacturers in 2015 32
3.4 Raw Materials Sources Analysis of Global Active Pharmaceutical Ingredient Major Manufacturers in 2015 34
4 Capacity, Production and Revenue Analysis of Active Pharmaceutical Ingredient by Regions, Types and Manufacturers 36
4.1 Global Capacity, Production and Revenue of Active Pharmaceutical Ingredient by Regions 2011-2016 36
4.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Active Pharmaceutical Ingredient 2011-2016 40
4.3 Global Capacity, Production and Revenue of Active Pharmaceutical Ingredient by Types 2011-2016 48
4.4 Global Capacity, Production and Revenue of Active Pharmaceutical Ingredient by Manufacturers 2011-2016 51
5 Price, Cost, Gross and Gross Margin Analysis of Active Pharmaceutical Ingredient by Regions, Types and Manufacturers 56
5.1 Price and Gross Margin Analysis of Active Pharmaceutical Ingredient by Regions 2011-2016 56
5.2 Price Analysis of Active Pharmaceutical Ingredient by Types 2011-2016 58
5.3 Gross Margin Analysis of Active Pharmaceutical Ingredient by Manufacturers 2011-2016 59
6 Consumption Volume Analysis of Active Pharmaceutical Ingredient by Regions, Types and Applications 61
6.1 Global Consumption Volume of Active Pharmaceutical Ingredient by Regions 2011-2016 61
6.2 Global and Major Regions Consumption Volume and Growth Rate of Active Pharmaceutical Ingredient 2011-2016 63
6.3 Global Consumption Volume of Active Pharmaceutical Ingredient by Applications 2011-2016 66
7 Supply, Import, Export and Consumption Analysis of Active Pharmaceutical Ingredient 68
7.1 Supply, Consumption and Gap of Active Pharmaceutical Ingredient 2011-2016 68
7.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Active Pharmaceutical Ingredient 2011-2016 69
7.3 US Capacity, Production, Revenue and Gross Margin of Active Pharmaceutical Ingredient 2011-2016 69
7.4 EU Capacity, Production, Revenue and Gross Margin of Active Pharmaceutical Ingredient 2011-2016 70
7.5 China Capacity, Production, Revenue, Supply and Gross Margin of Active Pharmaceutical Ingredient 2011-2016 70
7.6 India Capacity, Production, Revenue and Gross Margin of Active Pharmaceutical Ingredient 2011-2016 71
8 Major Manufacturers Analysis of Active Pharmaceutical Ingredient 72
8.1 Teva 72
8.1.1 Company Profile 72
8.1.2 Product Picture and Specifications 72
8.1.3 Capacity, Production, Price, Cost, Gross and Revenue 73
8.1.4 Contact Information 75
8.2 Novartis 75
8.2.1 Company Profile 75
8.2.2 Product Picture and Specifications 76
8.2.3 Capacity, Production, Price, Cost, Gross and Revenue 76
8.2.4 Contact Information 78
8.3 Pfizer 78
8.3.1 Company Profile 78
8.3.2 Product Picture and Specifications 79
8.3.3 Capacity, Production, Price, Cost, Gross and Revenue 79
8.3.4 Contact Information 81
8.4 Johnson & Johnson 81
8.4.1 Company Profile 81
8.4.2 Product Picture and Specifications 82
8.4.3 Capacity, Production, Price, Cost, Gross and Revenue 82
8.4.4 Contact Information 84
8.5 Mylan 84
8.5.1 Company Profile 84
8.5.2 Product Picture and Specifications 85
8.5.3 Capacity, Production, Price, Cost, Gross and Revenue 85
8.5.4 Contact Information 87
8.6 North China Pharmaceutical Group 87
8.6.1 Company Profile 87
8.6.2 Product Picture and Specifications 88
8.6.3 Capacity, Production, Price, Cost, Gross and Revenue 89
8.6.4 Contact Information 90
8.7 Dr. Reddys Laboratories 90
8.7.1 Company Profile 90
8.7.2 Product Picture and Specifications 91
8.7.3 Capacity, Production, Price, Cost, Gross and Revenue 91
8.7.4 Contact Information 93
8.8 Roche 93
8.8.1 Company Profile 93
8.8.2 Product Picture and Specifications 94
8.8.3 Capacity, Production, Price, Cost, Gross and Revenue 94
8.8.4 Contact Information 95
8.9 Aurobindo pharma 95
8.9.1 Company Profile 96
8.9.2 Product Picture and Specifications 96
8.9.3 Capacity, Production, Price, Cost, Gross and Revenue 97
8.9.4 Contact Information 99
8.10 Sun Pharmaceutical Industries 99
8.10.1 Company Profile 99
8.10.2 Product Picture and Specifications 100
8.10.3 Capacity, Production, Price, Cost, Gross and Revenue 101
8.10.4 Contact Information 103
8.11 Boehringer Ingelheim GmbH 103
8.11.1 Company Profile 103
8.11.2 Product Picture and Specifications 104
8.11.3 Capacity, Production, Price, Cost, Gross and Revenue 104
8.11.4 Contact Information 106
8.12 Bayer 106
8.12.1 Company Profile 106
8.12.2 Product Picture and Specifications 107
8.12.3 Capacity, Production, Price, Cost, Gross and Revenue 107
8.12.4 Contact Information 108
8.13 BASF 108
8.13.1 Company Profile 108
8.13.2 Product Picture and Specifications 109
8.13.3 Capacity, Production, Price, Cost, Gross and Revenue 110
8.13.4 Contact Information 111
8.14 DSM 111
8.14.1 Company Profile 111
8.14.2 Product Picture and Specifications 112
8.14.3 Capacity, Production, Price, Cost, Gross and Revenue 113
8.14.4 Contact Information 114
8.15 Zhejiang Medicine 114
8.15.1 Company Profile 115
8.15.2 Product Picture and Specifications 115
8.15.3 Capacity, Production, Price, Cost, Gross and Revenue 116
8.15.4 Contact Information 118
8.16 Biocon 118
8.16.1 Company Profile 118
8.16.2 Product Picture and Specifications 119
8.16.3 Capacity, Production, Price, Cost, Gross and Revenue 119
8.16.4 Contact Information 121
8.17 Johnson Matthey 121
8.17.1 Company Profile 121
8.17.2 Product Picture and Specifications 122
8.17.3 Capacity, Production, Price, Cost, Gross and Revenue 122
8.17.4 Contact Information 124
8.18 Hisun Pharmacy 124
8.18.1 Company Profile 124
8.18.2 Product Picture and Specifications 125
8.18.3 Capacity, Production, Price, Cost, Gross and Revenue 126
8.18.4 Contact Information 127
8.19 Cambrex 127
8.19.1 Company Profile 127
8.19.2 Product Picture and Specifications 128
8.19.3 Capacity, Production, Price, Cost, Gross and Revenue 130
8.19.4 Contact Information 132
8.20 Shandong Xinhua Pharmaceutical 132
8.20.1 Company Profile 132
8.20.2 Product Picture and Specifications 133
8.20.3 Capacity, Production, Price, Cost, Gross and Revenue 134
8.20.4 Contact Information 136
8.21 Lonza group 136
8.21.1 Company Profile 136
8.21.2 Product Picture and Specifications 137
8.21.3 Capacity, Production, Price, Cost, Gross and Revenue 137
8.21.4 Contact Information 139
8.22 Huahai Pharmaceutical 139
8.22.1 Company Profile 139
8.22.2 Product Picture and Specifications 140
8.22.3 Capacity, Production, Price, Cost, Gross and Revenue 141
8.22.4 Contact Information 142
8.23 Haerbin Pharmaceutical Group 142
8.23.1 Company Profile 143
8.23.2 Product Picture and Specifications 143
8.23.3 Capacity, Production, Price, Cost, Gross and Revenue 144
8.23.4 Contact Information 145
8.24 Cipla 145
8.24.1 Company Profile 145
8.24.2 Product Picture and Specifications 146
8.24.3 Capacity, Production, Price, Cost, Gross and Revenue 146
8.24.4 Contact Information 148
8.25 Tian Yao 148
8.25.1 Company Profile 148
8.25.2 Product Picture and Specifications 149
8.25.3 Capacity, Production, Price, Cost, Gross and Revenue 150
8.25.4 Contact Information 151
8.26 Lupin 151
8.26.1 Company Profile 151
8.26.2 Product Picture and Specifications 152
8.26.3 Capacity, Production, Price, Cost, Gross and Revenue 156
8.26.4 Contact Information 157
8.27 North East Pharmaceutical 157
8.27.1 Company Profile 158
8.27.2 Product Picture and Specifications 158
8.27.3 Capacity, Production, Price, Cost, Gross and Revenue 159
8.27.4 Contact Information 160
8.28 Albemarle 160
8.28.1 Company Profile 160
8.28.2 Product Picture and Specifications 161
8.28.3 Capacity, Production, Price, Cost, Gross and Revenue 162
8.28.4 Contact Information 164
8.29 Shandong Lukang Pharmaceutical 164
8.29.1 Company Profile 164
8.29.2 Product Picture and Specifications 165
8.29.3 Capacity, Production, Price, Cost, Gross and Revenue 166
8.29.4 Contact Information 167
8.30 Jiangsu?Hengrui Medicine 167
8.30.1 Company Profile 168
8.30.2 Product Picture and Specifications 168
8.30.3 Capacity, Production, Price, Cost, Gross and Revenue 168
8.30.4 Contact Information 170
8.31 Bachem 170
8.31.1 Company Profile 170
8.31.2 Product Picture and Specifications 170
8.31.3 Capacity, Production, Price, Cost, Gross and Revenue 171
8.31.4 Contact Information 172
9 Marketing Trader or Distributor Analysis of Active Pharmaceutical Ingredient 173
9.1 Marketing Channels Status of Active Pharmaceutical Ingredient 173
9.2 Traders or Distributors with Contact Information of Active Pharmaceutical Ingredient by Regions 175
10 Industry Chain Analysis of Active Pharmaceutical Ingredient 176
10.1 Upstream Major Raw Materials Suppliers Analysis of Active Pharmaceutical Ingredient 176
10.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Active Pharmaceutical Ingredient 176
10.1.2 Major Raw Materials Suppliers with R&D State Analysis of Active Pharmaceutical Ingredient by Regions 177
10.2 Upstream Major Equipment Suppliers Analysis of Active Pharmaceutical Ingredient 178
10.2.1 Major Equipment Suppliers with Contact Information Analysis of Active Pharmaceutical Ingredient 178
10.2.2 Major Equipment Suppliers with Product Pictures Analysis of Active Pharmaceutical Ingredient by Regions 179
10.3 Downstream Major Consumers Analysis of Active Pharmaceutical Ingredient 182
10.3.1 Manufacturing Mode Analysis of Active Pharmaceutical Ingredient 182
10.3.2 Major Consumers with Contact Information Analysis of Active Pharmaceutical Ingredient 183
10.3.2 Major Consumers with Consumption Volume Analysis of Active Pharmaceutical Ingredient 184
10.4 Supply Chain Relationship Analysis of Active Pharmaceutical Ingredient 185
11 Development Trend of Analysis of Active Pharmaceutical Ingredient 187
11.1 Capacity, Production and Revenue Forecast of Active Pharmaceutical Ingredient by Regions and Types 187
11.1.1 Global Capacity, Production and Revenue of Active Pharmaceutical Ingredient by Regions 2016-2021 187
11.1.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Active Pharmaceutical Ingredient 2016-2021 191
11.1.3 Global Capacity, Production and Revenue of Active Pharmaceutical Ingredient by Types 2016-2021 199
11.2 Consumption Volume Forecast of Active Pharmaceutical Ingredient by Regions, Types and Applications 202
11.2.1 Global Consumption Volume of Active Pharmaceutical Ingredient by Regions 2016-2021 202
11.2.2 Global and Major Regions Consumption Volume and Growth Rate of Active Pharmaceutical Ingredient 2016-2021 203
11.2.3 Global Consumption Volume of Active Pharmaceutical Ingredient by Applications 2016-2021 206
11.3 Supply and Consumption Forecast of Active Pharmaceutical Ingredient 207
11.3.1 Supply, Consumption and Gap of Active Pharmaceutical Ingredient 2016-2021 207
11.3.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Active Pharmaceutical Ingredient 2016-2021 208
11.3.3 US Capacity, Production, Revenue, Supply and Consumption of Active Pharmaceutical Ingredient 2016-2021 209
11.3.4 EU Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Active Pharmaceutical Ingredient 2016-2021 209
11.3.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Active Pharmaceutical Ingredient 2016-2021 210
11.3.6 India Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Active Pharmaceutical Ingredient 2016-2021 210
12 New Project Investment Feasibility Analysis of Active Pharmaceutical Ingredient 211
12.1 New Project SWOT Analysis of Active Pharmaceutical Ingredient 211
12.2 New Project Investment Feasibility Analysis of Active Pharmaceutical Ingredient 212
13 Conclusion of the Global Active Pharmaceutical Ingredient Industry 2016 Market Research Report 213


List Of Tables and Figures
Figure Picture of Active Pharmaceutical Ingredient 1
Table Authority Agency Definition of Active Pharmaceutical Ingredient 1
Table Major Types of Active Pharmaceutical Ingredient 2
Table Specification Comparison of Different Types of Active Pharmaceutical Ingredient 3
Figure Global Production Market Share of Active Pharmaceutical Ingredient by Manufacturing Types in 2015 4
Figure Synthetic API Picture 5
Figure Biotech API Picture 6
Table Applications of Active Pharmaceutical Ingredient by Therapeutic Area 6
Figure Global Consumption Volume Market Share of Active Pharmaceutical Ingredient by Applications in 2015 8
Figure Industry Chain Structure of Active Pharmaceutical Ingredient 8
Table Industry Policy of Active Pharmaceutical Ingredient 11
Table Application of Q7 to API Manufacturing 14
Table Industry News List of Active Pharmaceutical Ingredient 15
Table Major Materials Responding to Various types of Manufacturing 17
Table Major Materials of Different API 17
Figure Picture of M-Cresol 18
Figure Picture of Corn Starch 19
Table Specification of Food Grade Corn Starch 19
Figure Sales Market Share by Application of Corn Starch in 2015 20
Table Corn Starch Production (K Tonnes) by Regions 2010-2015 20
Figure Corn Starch Price Analysis 2010-2015 21
Table Raw Material Suppliers of Active Pharmaceutical Ingredient 21
Table Equipment Suppliers and Price Analysis 22
Figure Manufacturing Labor Cost Per Hour in China as a Proportion of Those in Other Countries (%) 23
Figure Manufacturing Labor Costs in Select Provinces and Countries in 2014 24
Figure Average Manufacturing Cost Index in 2014 24
Figure Average Manufacturing Cost Index in 2014 25
Table Global Electricity Price of Industry (USD/KWh) by Country in 2014 25
Table US Average Price of Electricity to Ultimate Customers by End-Use Sector, by State, September 2015 and 2014 (Cents per KWh) 26
Table India Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient in 2015 29
Figure Manufacturing Process Analysis of Active Pharmaceutical Ingredient 29
Table Production Revenue (Million USD) and Commercial Production Date of Global Active Pharmaceutical Ingredient Major Manufacturers in 2015 30
Table Manufacturing Plants Distribution of Global Active Pharmaceutical Ingredient Major Manufacturers in 2015 31
Table R&D Status of Global Active Pharmaceutical Ingredient Major Manufacturers in 2015 32
Table Raw Materials Sources Analysis of Global Active Pharmaceutical Ingredient Major Manufacturers in 2015 34
Table Global Capacity (K Tonnes) of Active Pharmaceutical Ingredient by Regions 2011-2016 36
Figure Global Capacity Market Share of Active Pharmaceutical Ingredient by Regions in 2011 37
Figure Global Capacity Market Share of Active Pharmaceutical Ingredient by Regions in 2015 37
Table Global Production (K Tonnes) of Active Pharmaceutical Ingredient by Regions 2011-2016 37
Figure Global Production Market Share of Active Pharmaceutical Ingredient by Regions in 2011 38
Figure Global Production Market Share of Active Pharmaceutical Ingredient by Regions in 2015 38
Table Global Revenue (Million USD) of Active Pharmaceutical Ingredient by Regions 2011-2016 39
Figure Global Revenue Market Share of Active Pharmaceutical Ingredient by Regions in 2011 39
Figure Global Revenue Market Share of Active Pharmaceutical Ingredient by Regions in 2015 40
Figure Global Capacity (K Tonnes), Production (K Tonnes) and Growth Rate of Active Pharmaceutical Ingredient 2011-2016 40
Figure Global Capacity Utilization Rate of Active Pharmaceutical Ingredient 2011-2016 41
Figure Global Revenue (Million USD) and Growth Rate of Active Pharmaceutical Ingredient 2011-2016 41
Figure US Capacity (K Tonnes), Production (K Tonnes) and Growth Rate of Active Pharmaceutical Ingredient 2011-2016 42
Figure US Capacity Utilization Rate of Active Pharmaceutical Ingredient 2011-2016 42
Figure US Revenue (Million USD) and Growth Rate of Active Pharmaceutical Ingredient 2011-2016 43
Figure EU Capacity (K Tonnes), Production (K Tonnes) and Growth Rate of Active Pharmaceutical Ingredient 2011-2016 43
Figure EU Capacity Utilization Rate of Active Pharmaceutical Ingredient 2011-2016 44
Figure EU Revenue (Million USD) and Growth Rate of Active Pharmaceutical Ingredient 2011-2016 44
Figure China Capacity (K Tonnes), Production (K Tonnes) and Growth Rate of Active Pharmaceutical Ingredient 2011-2016 45
Figure China Capacity Utilization Rate of Active Pharmaceutical Ingredient 2011-2016 45
Figure China Revenue (Million USD) and Growth Rate of Active Pharmaceutical Ingredient 2011-2016 46
Figure India Capacity (K Tonnes), Production (K Tonnes) and Growth Rate of Active Pharmaceutical Ingredient 2011-2016 46
Figure India Capacity Utilization Rate of Active Pharmaceutical Ingredient 2011-2016 47
Figure India Revenue (Million USD) and Growth Rate of Active Pharmaceutical Ingredient 2011-2016 47
Table Global Production (K Tonnes) of Active Pharmaceutical Ingredient by Types 2011-2016 48
Figure Global Production Market Share of Active Pharmaceutical Ingredient by Types in 2011 48
Figure Global Production Market Share of Active Pharmaceutical Ingredient by Types in 2015 49
Table Global Revenue (Million USD) of Active Pharmaceutical Ingredient by Types 2011-2016 49
Figure Global Revenue Market Share of Active Pharmaceutical Ingredient by Types in 2011 50
Figure Global Revenue Market Share of Active Pharmaceutical Ingredient by Types in 2015 50
Table Global and Major Manufacturers Revenue (Million USD) of Active Pharmaceutical Ingredient 2011-2016 51
Table Global Revenue Market Share of Active Pharmaceutical Ingredient Major Manufacturers 2011-2016 52
Figure Global Revenue Market Share of Active Pharmaceutical Ingredient Major Manufacturers in 2011 54
Figure Global Revenue Market Share of Active Pharmaceutical Ingredient Major Manufacturers in 2015 55
Table Price (USD/Tonne) of Active Pharmaceutical Ingredient by Regions 2011-2016 56
Figure Price (USD/Tonne) of Active Pharmaceutical Ingredient by Regions in 2015 57
Table Gross Margin of Active Pharmaceutical Ingredient by Regions 2011-2016 57
Figure Gross Margin of Active Pharmaceutical Ingredient by Regions in 2015 58
Table Price (USD/Tonne) of Active Pharmaceutical Ingredient by Types 2011-2016 58
Figure Price (USD/Tonne) of Active Pharmaceutical Ingredient by Types in 2015 59
Table Gross Margin of Active Pharmaceutical Ingredient by Manufacturers 2011-2016 59
Table Global Consumption Volume (K Tonnes) of Active Pharmaceutical Ingredient by Regions 2011-2016 61
Figure Global Consumption Volume Market Share of Active Pharmaceutical Ingredient by Regions in 2011 61
Figure Global Consumption Volume Market Share of Active Pharmaceutical Ingredient by Regions in 2015 62
Figure Global Consumption Volume (K Tonnes) and Growth Rate of Active Pharmaceutical Ingredient 2011-2016 63
Figure US Consumption Volume (K Tonnes) and Growth Rate of Active Pharmaceutical Ingredient 2011-2016 64
Figure EU Consumption Volume (K Tonnes) and Growth Rate of Active Pharmaceutical Ingredient 2011-2016 64
Figure China Consumption Volume (K Tonnes) and Growth Rate of Active Pharmaceutical Ingredient 2011-2016 65
Figure India Consumption Volume (K Tonnes) and Growth Rate of Active Pharmaceutical Ingredient 2011-2016 65
Table Global Consumption Volume (K Tonnes) of Active Pharmaceutical Ingredient by Applications 2011-2016 66
Figure Global Consumption Volume Market Share of Active Pharmaceutical Ingredient by Applications in 2011 66
Figure Global Consumption Volume Market Share of Active Pharmaceutical Ingredient by Applications in 2015 67
Table Global Supply, Consumption and Gap of Active Pharmaceutical Ingredient 2011-2016 (K Tonnes) 68
Table US Supply, Consumption and Gap of Active Pharmaceutical Ingredient 2011-2016 (K Tonnes) 68
Table EU Supply, Consumption and Gap of Active Pharmaceutical Ingredient 2011-2016 (K Tonnes) 68
Table China Supply, Consumption and Gap of Active Pharmaceutical Ingredient 2011-2016 (K Tonnes) 68
Table India Supply, Consumption and Gap of Active Pharmaceutical Ingredient 2011-2016 (K Tonnes) 69
Table Global Capacity (K Tonnes), Production (K Tonnes), Revenue (Million USD) and Gross Margin of Active Pharmaceutical Ingredient 2011-2016 69
Table US Capacity (K Tonnes), Production (K Tonnes), Revenue (Million USD) and Gross Margin of Active Pharmaceutical Ingredient 2011-2016 69
Table EU Capacity (K Tonnes), Production (K Tonnes), Revenue (Million USD) and Gross Margin of Active Pharmaceutical Ingredient 2011-2016 70
Table China Capacity (K Tonnes), Production (K Tonnes), Revenue (Million USD) and Gross Margin of Active Pharmaceutical Ingredient 2011-2016 70
Table Capacity (K Tonnes), Production (K Tonnes), Revenue (Million USD) and Gross Margin of Active Pharmaceutical Ingredient 2011-2016 71
Table Teva Information List 72
Table Part of Active Pharmaceutical Ingredient Specifications of Teva 72
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Teva 2011-2016 73
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Teva 2011-2016 74
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Teva 2011-2016 74
Table Contact Information of Teva 75
Table Novartis Information List 75
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Novartis 2011-2016 76
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Novartis 2011-2016 77
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Novartis 2011-2016 77
Table Contact Information of Novartis 78
Table Pfizer Information List 78
Table Part of Active Pharmaceutical Ingredient Specifications of Pfizer 79
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Pfizer 2011-2016 79
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Pfizer 2011-2016 80
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Pfizer 2011-2016 80
Table Contact Information of Pfizer 81
Table Johnson & Johnson Information List 81
Table Active Pharmaceutical Ingredient Picture and Specifications of Johnson&Johnson 82
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Johnson & Johnson 2011-2016 82
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Johnson & Johnson 2011-2016 83
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Johnson & Johnson 2011-2016 83
Table Contact Information of Johnson & Johnson 84
Table Mylan Information List 84
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Mylan 2011-2016 85
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Mylan 2011-2016 86
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Mylan 2011-2016 86
Table Contact Information of Mylan 87
Table North China Pharmaceutical Group Information List 87
Table Active Pharmaceutical Ingredient Picture and Specifications of North China Pharmaceutical Group 88
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of North China Pharmaceutical Group 2011-2016 89
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of North China Pharmaceutical Group 2011-2016 89
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of North China Pharmaceutical Group 2011-2016 90
Table Contact Information of North China Pharmaceutical Group 90
Table Dr. Reddy’s Laboratories Information List 90
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Dr. Reddy’s Laboratories 2011-2016 91
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Dr. Reddy’s Laboratories 2011-2016 92
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Dr. Reddy’s Laboratories 2011-2016 92
Table Contact Information of Dr. Reddy’s Laboratories 93
Table Roche Information List 93
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Roche 2011-2016 94
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Roche 2011-2016 94
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Roche 2011-2016 95
Table Contact Information of Roche 95
Table Aurobindo pharma Information List 96
Table Part of Active Pharmaceutical Ingredient Picture and Specifications of Aurobindo pharma 96
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Aurobindo pharma 2011-2016 97
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Aurobindo pharma 2011-2016 98
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Aurobindo pharma 2011-2016 98
Table Contact Information of Aurobindo pharma 99
Table Sun Pharmaceutical Industries Information List 99
Table Part of Active Pharmaceutical Ingredients of Sun Pharmaceutical Industries 100
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Sun Pharmaceutical Industries 2011-2016 101
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Sun Pharmaceutical Industries 2011-2016 102
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Sun Pharmaceutical Industries 2011-2016 102
Table Contact Information of Sun Pharmaceutical Industries 103
Table Boehringer Ingelheim GmbH Information List 103
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Boehringer Ingelheim GmbH 2011-2016 104
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Boehringer Ingelheim GmbH 2011-2016 105
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Boehringer Ingelheim GmbH 2011-2016 105
Table Contact Information of Boehringer Ingelheim GmbH 106
Table Bayer Information List 106
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Bayer 2011-2016 107
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Bayer 2011-2016 107
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Bayer 2011-2016 108
Table Contact Information of Bayer 108
Table BASF Information List 108
Table Active Pharmaceutical Ingredient Specifications of BASF 109
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of BASF 2011-2016 110
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of BASF 2011-2016 110
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of BASF 2011-2016 111
Table Contact Information of BASF 111
Table DSM Information List 111
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of DSM 2011-2016 113
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of DSM 2011-2016 113
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of DSM 2011-2016 114
Table Contact Information of DSM 114
Table Zhejiang Medicine Information List 115
Table Active Pharmaceutical Ingredient Picture and Specifications of Zhejiang Medicine 115
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Zhejiang Medicine 2011-2016 116
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Zhejiang Medicine 2011-2016 117
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Zhejiang Medicine 2011-2016 117
Table Contact Information of Zhejiang Medicine 118
Table Biocon Information List 118
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Biocon 2011-2016 119
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Biocon 2011-2016 120
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Biocon 2011-2016 120
Table Contact Information of Biocon 121
Table Johnson Matthey Information List 121
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Johnson Matthey 2011-2016 122
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Johnson Matthey 2011-2016 123
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Johnson Matthey 2011-2016 123
Table Contact Information of Johnson Matthey 124
Table Hisun Pharmacy Information List 124
Table Active Pharmaceutical Ingredient Picture and Specifications of Hisun Pharmacy 125
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Hisun Pharmacy 2011-2016 126
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Hisun Pharmacy 2011-2016 126
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Hisun Pharmacy 2011-2016 127
Table Contact Information of Hisun Pharmacy 127
Table Cambrex Information List 127
Table Part of Active Pharmaceutical Ingredient Specifications of Cambrex 128
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Cambrex 2011-2016 130
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Cambrex 2011-2016 131
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Cambrex 2011-2016 131
Table Contact Information of Cambrex 132
Table Shandong Xinhua Pharmaceutical Information List 132
Table Active Pharmaceutical Ingredient Picture and Specifications of Shandong Xinhua Pharmaceutical 133
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Shandong Xinhua Pharmaceutical 2011-2016 134
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Shandong Xinhua Pharmaceutical 2011-2016 135
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Shandong Xinhua Pharmaceutical 2011-2016 135
Table Contact Information of Shandong Xinhua Pharmaceutical 136
Table Lonza group Information List 136
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Lonza group 2011-2016 137
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Lonza group 2011-2016 138
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Lonza group 2011-2016 138
Table Contact Information of Lonza group 139
Table Huahai Pharmaceutical Information List 139
Table Part of Active Pharmaceutical Ingredient Specifications of Huahai Pharmaceutical 140
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Huahai Pharmaceutical 2011-2016 141
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Huahai Pharmaceutical 2011-2016 141
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Huahai Pharmaceutical 2011-2016 142
Table Contact Information of Huahai Pharmaceutical 142
Table Haerbin Pharmaceutical Group Information List 143
Table Part of Active Pharmaceutical Ingredient Specifications of Haerbin Pharmaceutical Group 143
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Haerbin Pharmaceutical Group 2011-2016 144
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Haerbin Pharmaceutical Group 2011-2016 144
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Haerbin Pharmaceutical Group 2011-2016 145
Table Contact Information of Haerbin Pharmaceutical Group 145
Table Cipla Information List 145
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Cipla 2011-2016 146
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Cipla 2011-2016 147
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Cipla 2011-2016 147
Table Contact Information of Cipla 148
Table Tian Yao Information List 148
Table Active Pharmaceutical Ingredient Picture and Specifications of Tian Yao 149
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Tian Yao 2011-2016 150
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Tian Yao 2011-2016 150
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Tian Yao 2011-2016 151
Table Contact Information of Tian Yao 151
Table Lupin Information List 151
Table Active Pharmaceutical Ingredient Picture and Specifications of Lupin 152
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Lupin 2011-2016 156
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Lupin 2011-2016 156
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Lupin 2011-2016 157
Table Contact Information of Lupin 157
Table North East Pharmaceutical Information List 158
Table Part of Active Pharmaceutical Ingredient Specifications of North East Pharmaceutical 158
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of North East Pharmaceutical 2011-2016 159
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of North East Pharmaceutical 2011-2016 159
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of North East Pharmaceutical 2011-2016 160
Table Contact Information of North East Pharmaceutical 160
Table Albemarle Information List 160
Table Active Pharmaceutical Ingredient Specifications of Albemarle 161
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Albemarle 2011-2016 162
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Albemarle 2011-2016 163
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Albemarle 2011-2016 163
Table Contact Information of Albemarle 164
Table Shandong Lukang Pharmaceutical Information List 164
Table Active Pharmaceutical Ingredient Specifications of Shandong Lukang Pharmaceutical 165
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Shandong Lukang Pharmaceutical 2011-2016 166
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Shandong Lukang Pharmaceutical 2011-2016 166
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Shandong Lukang Pharmaceutical 2011-2016 167
Table Contact Information of Shandong Lukang Pharmaceutical 167
Table Jiangsu?Hengrui Medicine Information List 168
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Jiangsu?Hengrui Medicine 2011-2016 168
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Jiangsu?Hengrui Medicine 2011-2016 169
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Jiangsu?Hengrui Medicine 2011-2016 169
Table Contact Information of Jiangsu?Hengrui Medicine 170
Table Bachem Information List 170
Table Active Pharmaceutical Ingredient Revenue (Million USD) and Gross Margin of Bachem 2011-2016 171
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate of Bachem 2011-2016 171
Figure Active Pharmaceutical Ingredient Revenue (Million USD) and Global Market Share of Bachem 2011-2016 172
Table Contact Information of Bachem 172
Figure Submission of Different Parts of an APIMF during the APIMF Procedure 173
Figure Marketing Channels of Active Pharmaceutical Ingredient 174
Figure Chinese Pharmaceutical Industry Value Chain 174
Table Traders or Distributors with Contact Information of Active Pharmaceutical Ingredient by Regions 175
Table Major Raw Materials Suppliers with Contact Information of Active Pharmaceutical Ingredient 176
Table Major Raw Materials Suppliers with R&D State Analysis of Active Pharmaceutical Ingredient by Regions 177
Table Major Equipment Suppliers with Contact Information of Active Pharmaceutical Ingredient 178
Table Major Equipment Suppliers with Product Pictures of Active Pharmaceutical Ingredient by Regions 179
Figure Pharmaceutical Manufacturing via Batch Processes 182
Figure Schematic of Integrated Continuous Manufacturing (ICM) of Pharmaceuticals 183
Table Major Consumers with Contact Information of Active Pharmaceutical Ingredient 183
Figure Ranking of the Global Top 10 Biotech and Pharmaceutical Companies Based on Net Income in 2015 (Billion USD) 184
Table Supply Chain Relationship Analysis of Active Pharmaceutical Ingredient 185
Table Global Capacity (K Tonnes) of Active Pharmaceutical Ingredient by Regions 2016-2021 187
Figure Global Capacity Market Share of Active Pharmaceutical Ingredient by Regions in 2016 188
Figure Global Capacity Market Share of Active Pharmaceutical Ingredient by Regions in 2021 188
Table Global Production (K Tonnes) of Active Pharmaceutical Ingredient by Regions 2016-2021 188
Figure Global Production Market Share of Active Pharmaceutical Ingredient by Regions in 2016 189
Figure Global Production Market Share of Active Pharmaceutical Ingredient by Regions in 2021 189
Table Global Revenue (Million USD) of Active Pharmaceutical Ingredient by Regions 2016-2021 190
Figure Global Revenue Market Share of Active Pharmaceutical Ingredient by Regions in 2016 190
Figure Global Revenue Market Share of Active Pharmaceutical Ingredient by Regions in 2021 191
Figure Global Capacity (K Tonnes), Production (K Tonnes) and Growth Rate of Active Pharmaceutical Ingredient 2016-2021 191
Figure Global Capacity Utilization Rate of Active Pharmaceutical Ingredient 2016-2021 192
Figure Global Revenue (Million USD) and Growth Rate of Active Pharmaceutical Ingredient 2016-2021 192
Figure US Capacity (K Tonnes), Production (K Tonnes) and Growth Rate of Active Pharmaceutical Ingredient 2016-2021 193
Figure US Capacity Utilization Rate of Active Pharmaceutical Ingredient 2016-2021 193
Figure US Revenue (Million USD) and Growth Rate of Active Pharmaceutical Ingredient 2016-2021 194
Figure EU Capacity (K Tonnes), Production (K Tonnes) and Growth Rate of Active Pharmaceutical Ingredient 2016-2021 194
Figure EU Capacity Utilization Rate of Active Pharmaceutical Ingredient 2016-2021 195
Figure EU Revenue (Million USD) and Growth Rate of Active Pharmaceutical Ingredient 2016-2021 195
Figure China Capacity (K Tonnes), Production (K Tonnes) and Growth Rate of Active Pharmaceutical Ingredient 2016-2021 196
Figure China Capacity Utilization Rate of Active Pharmaceutical Ingredient 2016-2021 196
Figure China Revenue (Million USD) and Growth Rate of Active Pharmaceutical Ingredient 2016-2021 197
Figure India Capacity (K Tonnes), Production (K Tonnes) and Growth Rate of Active Pharmaceutical Ingredient 2016-2021 197
Figure India Capacity Utilization Rate of Active Pharmaceutical Ingredient 2016-2021 198
Figure India Revenue (Million USD) and Growth Rate of Active Pharmaceutical Ingredient 2016-2021 198
Table Global Production (K Tonnes) of Active Pharmaceutical Ingredient by Types 2016-2021 199
Figure Global Production Market Share of Active Pharmaceutical Ingredient by Types in 2016 199
Figure Global Production Market Share of Active Pharmaceutical Ingredient by Types in 2021 200
Table Global Revenue (Million USD) of Active Pharmaceutical Ingredient by Types 2016-2021 200
Figure Global Revenue Market Share of Active Pharmaceutical Ingredient by Types in 2016 201
Figure Global Revenue Market Share of Active Pharmaceutical Ingredient by Types in 2021 201
Table Global Consumption Volume (K Tonnes) of Active Pharmaceutical Ingredient by Regions 2016-2021 202
Figure Global Consumption Volume Market Share of Active Pharmaceutical Ingredient by Regions in 2016 202
Figure Global Consumption Volume Market Share of Active Pharmaceutical Ingredient by Regions in 2021 203
Figure Global Consumption Volume (K Tonnes) and Growth Rate of Active Pharmaceutical Ingredient 2016-2021 203
Figure US Consumption Volume (K Tonnes) and Growth Rate of Active Pharmaceutical Ingredient 2016-2021 204
Figure EU Consumption Volume (K Tonnes) and Growth Rate of Active Pharmaceutical Ingredient 2016-2021 204
Figure China Consumption Volume (K Tonnes) and Growth Rate of Active Pharmaceutical Ingredient 2016-2021 205
Figure India Consumption Volume (K Tonnes) and Growth Rate of Active Pharmaceutical Ingredient 2016-2021 205
Table Global Consumption Volume (K Tonnes) of Active Pharmaceutical Ingredient by Applications 2016-2021 206
Figure Global Consumption Volume Market Share of Active Pharmaceutical Ingredient by Applications in 2016 206
Figure Global Consumption Volume Market Share of Active Pharmaceutical Ingredient by Applications in 2021 207
Table Global Supply, Consumption and Gap of Active Pharmaceutical Ingredient 2016-2021 (K Tonnes) 207
Table US Supply, Consumption and Gap of Active Pharmaceutical Ingredient 2016-2021 (K Tonnes) 207
Table EU Supply, Consumption and Gap of Active Pharmaceutical Ingredient 2016-2021 (K Tonnes) 208
Table China Supply, Consumption and Gap of Active Pharmaceutical Ingredient 2016-2021 (K Tonnes) 208
Table India Supply, Consumption and Gap of Active Pharmaceutical Ingredient 2016-2021 (K Tonnes) 208
Table Global Capacity (K Tonnes), Production (K Tonnes), Revenue (Million USD) and Gross Margin of Active Pharmaceutical Ingredient 2016-2021 208
Table US Capacity (K Tonnes), Production (K Tonnes), Revenue (Million USD) and Gross Margin of Active Pharmaceutical Ingredient 2016-2021 209
Table EU Capacity (K Tonnes), Production (K Tonnes), Revenue (Million USD) and Gross Margin of Active Pharmaceutical Ingredient 2016-2021 209
Table China Capacity (K Tonnes), Production (K Tonnes), Revenue (Million USD) and Gross Margin of Active Pharmaceutical Ingredient 2016-2021 210
Table India Capacity (K Tonnes), Production (K Tonnes), Revenue (Million USD) and Gross Margin of Active Pharmaceutical Ingredient 2016-2021 210
Table New Project SWOT Analysis of Active Pharmaceutical Ingredient 211
Table New Project Investment Feasibility Analysis of Active Pharmaceutical Ingredient 212

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.